D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
Snowflake
SNOW
|
+$429M |
| 3 |
Citigroup
C
|
+$383M |
| 4 |
Oracle
ORCL
|
+$365M |
| 5 |
Sea Limited
SE
|
+$360M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$597M |
| 2 |
Apple
AAPL
|
+$579M |
| 3 |
Mastercard
MA
|
+$525M |
| 4 |
Walt Disney
DIS
|
+$428M |
| 5 |
Booking.com
BKNG
|
+$416M |
Sector Composition
| 1 | Technology | 19.98% |
| 2 | Consumer Discretionary | 13.5% |
| 3 | Financials | 10.53% |
| 4 | Healthcare | 10.18% |
| 5 | Communication Services | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRC
1726
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $4.01M | ﹤0.01% |
83,135
+11,645
| +16% | +$561K |
|
|
NPABU
1727
DELISTED
New Providence Acquisition Corp. II Unit
NPABU
| $4M | ﹤0.01% |
+400,000
| New | +$4M |
|
|
ACBI
1728
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $4M | ﹤0.01% |
139,036
-52,011
| -27% | -$1.5M |
|
|
GRNA
1729
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
| $4M | ﹤0.01% |
403,120
+121,019
| +43% | +$1.2M |
|
|
BMAQ
1730
DELISTED
Blockchain Moon Acquisition Corp. Common Stock
BMAQ
| $4M | ﹤0.01% |
+408,375
| New | +$4M |
|
1731
SiriusPoint
SPNT
$2.22B
| $4M | ﹤0.01% |
491,560
-131,609
| -21% | -$1.07M |
|
1732
LivaNova
LIVN
$3.07B
| $3.98M | ﹤0.01% |
45,508
-19,068
| -30% | -$1.67M |
|
1733
Apple Hospitality REIT
APLE
$2.98B
| $3.97M | ﹤0.01% |
245,722
+86,298
| +54% | +$1.39M |
|
1734
Cimpress
CMPR
$1.4B
| $3.96M | ﹤0.01% |
55,234
-15,752
| -22% | -$1.13M |
|
|
SCOB
1735
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
| $3.95M | ﹤0.01% |
405,562
-148,248
| -27% | -$1.44M |
|
1736
WisdomTree
WT
$2.11B
| $3.94M | ﹤0.01% |
644,383
+8,095
| +1% | +$49.5K |
|
1737
SS&C Technologies
SSNC
$21.8B
| $3.94M | ﹤0.01% |
48,046
-157,491
| -77% | -$12.9M |
|
|
IBER
1738
DELISTED
Ibere Pharmaceuticals
IBER
| $3.93M | ﹤0.01% |
404,176
+242,637
| +150% | +$2.36M |
|
1739
TriMas Corp
TRS
$1.59B
| $3.92M | ﹤0.01% |
105,846
-23,464
| -18% | -$868K |
|
1740
8x8 Inc
EGHT
$286M
| $3.91M | ﹤0.01% |
233,527
+184,623
| +378% | +$3.09M |
|
1741
GoHealth
GOCO
$79.6M
| $3.91M | ﹤0.01% |
68,765
+67,918
| +8,019% | +$3.86M |
|
|
MSAC
1742
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $3.91M | ﹤0.01% |
402,255
+230,190
| +134% | +$2.24M |
|
|
AIMC
1743
DELISTED
Altra Industrial Motion Corp.
AIMC
| $3.91M | ﹤0.01% |
+75,781
| New | +$3.91M |
|
1744
Spectrum Brands
SPB
$1.29B
| $3.9M | ﹤0.01% |
38,365
+28,912
| +306% | +$2.94M |
|
|
YTPG
1745
DELISTED
TPG Pace Beneficial II Corp.
YTPG
| $3.88M | ﹤0.01% |
396,318
+120,830
| +44% | +$1.18M |
|
|
LOGC
1746
DELISTED
ContextLogic
LOGC
| $3.88M | ﹤0.01% |
41,534
+4,099
| +11% | +$382K |
|
|
IGMS
1747
DELISTED
IGM Biosciences
IGMS
| $3.87M | ﹤0.01% |
132,098
+116,413
| +742% | +$3.41M |
|
1748
iQIYI
IQ
$2.51B
| $3.87M | ﹤0.01% |
849,610
+632,005
| +290% | +$2.88M |
|
1749
Catalyst Pharmaceutical
CPRX
$2.44B
| $3.87M | ﹤0.01% |
571,787
+166,929
| +41% | +$1.13M |
|
1750
Mobix Labs
MOBX
$56.9M
| $3.87M | ﹤0.01% |
394,192
+111,775
| +40% | +$1.1M |
|